Integra LifeSciences’ third quarter was marked by operational disruptions and underwhelming revenue growth, resulting in a ...
Q3 2025 Management View John Engel, Chairman, President & CEO, stated, "We delivered very strong results in the third quarter, and we again outperformed the market with our leading portfolio of ...